Barclays’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.08M | Sell |
|
|||||
|
2025
Q2 | $4.36M | Sell |
|
|||||
|
2025
Q1 | $14.4M | Sell |
|
|||||
|
2024
Q4 | $8.49M | Sell |
|
|||||
|
2024
Q3 | $15.1M | Buy |
|
|||||
|
2024
Q2 | $8.59M | Sell |
|
|||||
|
2024
Q1 | $6.93M | Buy |
|
|||||
|
2023
Q4 | $5.9M | Buy |
|
|||||
|
2023
Q3 | $2.02M | Buy |
|
|||||
|
2023
Q2 | $1.59M | Sell |
|
|||||
|
2023
Q1 | $1.86M | Buy |
|
|||||
|
2022
Q4 | $1.74M | Buy |
|
|||||
|
2022
Q3 | $2.15M | Buy |
|
|||||
|
2022
Q2 | $1.82M | Sell |
|
|||||
|
2022
Q1 | $2.53M | Sell |
|
|||||
|
2021
Q4 | $3.43M | Buy |
|
|||||
|
2021
Q3 | $3.23M | Buy |
|
|||||
|
2021
Q2 | $1.61M | Sell |
|
|||||
|
2021
Q1 | $4.28M | Sell |
|
|||||
|
2020
Q4 | $5.54M | Sell |
|
|||||
|
2020
Q3 | $4.79M | Buy |
|
|||||
|
2020
Q2 | $4.39M | Buy |
|
|||||
|
2020
Q1 | $2.83M | Buy |
|
|||||
|
2019
Q4 | $2.54M | Buy |
|
|||||
|
2019
Q3 | $1.52M | Sell |
|
|||||
|
2019
Q2 | $1.27M | Buy |
|
|||||
|
2019
Q1 | $1.18M | Buy |
|
|||||
|
2018
Q4 | $691K | Sell |
|
|||||
|
2018
Q3 | $1.74M | Buy |
|
|||||
|
2018
Q2 | $602K | Buy |
|
|||||
|
2018
Q1 | $470K | Sell |
|
|||||
|
2017
Q4 | $1.26M | Sell |
|
|||||
|
2017
Q3 | $1.67M | Sell |
|
|||||
|
2017
Q2 | $1.44M | Buy |
|
|||||
|
2017
Q1 | $1.33M | Buy |
|
|||||
|
2016
Q4 | $719K | Buy |
|
|||||
|
2016
Q3 | $322K | Buy |
|
|||||
|
2016
Q2 | $11K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $20K | Buy |
|
|||||
|
2015
Q3 | $1K | Sell |
|
|||||
|
2015
Q2 | $24K | Sell |
|
|||||
|
2015
Q1 | $38K | Sell |
|
|||||
|
2014
Q4 | $29K | Buy |
|
|||||
|
2014
Q3 | $12K | Buy |
|
|||||
|
2014
Q2 | $11K | Sell |
|
|||||
|
2014
Q1 | $476K | Buy |
|
|||||
|
2013
Q4 | $3K | Sell |
|
|||||
|
2013
Q3 | $2K | Sell |
|
|||||
|
2013
Q2 | $5K | Buy |
|